Dramatically Advancing Drug Discovery

ZebiAI Therapeutics is focused on applying machine learning (ML) at all stages of small molecule drug discovery to accelerate target validation and advance new therapeutics for unmet medical needs.

Our core technology applies ML algorithms to vast amounts of high quality protein-small molecule interaction data to:

  • Accelerate target validation by providing high quality tool compounds to the research community
  • Rapidly discover and optimize novel chemical matter into clinical candidates

ZebiAI is powered by partnerships with DEL screening leader, X-Chem, and world-class leader in ML capabilities, Google.

Our Partners

Team

Brant Binder

President

Christelle Huguet, Ph.D.

Chair, Scientific Advisory Board

Richard Wagner, Ph.D.

Founder and Director